Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase I study of bortezomib in combination with irinotecan in patients with relapsed/refractory high-risk neuroblastoma.AuthorsMody, Rajen; Zhao, Lili; Yanik, Gregory Anthony; Opipari, ValeriePublicationPediatric Blood & Cancer, 2017, Vol 64, Issue 11, pn/aISSN1545-5009Publication typejournal articleDOI10.1002/pbc.26563